Antipsychotic-Induced Hyperprolactinaemia: Mechanisms, Clinical Features and Management

ISSN： 0012-6667

Source： Drugs, Vol.64, Iss.20, 2004-01, pp. : 2291-2314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antidepressant-Induced Hyperprolactinaemia: Incidence, Mechanisms and Management

By Coker Flora Taylor David

CNS Drugs, Vol. 24, Iss. 7, 2010-07 ,pp. : 563-574

Adis International

Access to resources Recommend Favorite

Antipsychotic-Induced Rabbit Syndrome: Epidemiology, Management and Pathophysiology

By Schwartz M.

CNS Drugs, Vol. 18, Iss. 4, 2004-01 ,pp. : 213-220

Adis International

Access to resources Recommend Favorite

Pharmacological Management of Atypical Antipsychotic-Induced Weight Gain

By Baptista Trino

CNS Drugs, Vol. 22, Iss. 6, 2008-01 ,pp. : 477-495

Adis International

Access to resources Recommend Favorite

Hyperprolactinaemia in Antipsychotic-Treated Patients: Guidelines for Avoidance and Management

By Hamner M.B. Arana G.W.

CNS Drugs, Vol. 10, Iss. 3, 1998-09 ,pp. : 209-222

Adis International

Access to resources Recommend Favorite

Atypical Antipsychotic-Induced Weight Gain: Insights into Mechanisms of Action

By Roerig James L. Steffen Kristine J. Mitchell James E.

CNS Drugs, Vol. 25, Iss. 12, 2011-12 ,pp. : 1035-1059

Adis International

Access to resources Recommend Favorite